The stock of Clover Health Investments Corp (CLOV) has seen a -0.98% decrease in the past week, with a -13.47% drop in the past month, and a -20.25% decrease in the past quarter. The volatility ratio for the week is 0.85%, and the volatility levels for the past 30 days are at 2.51% for CLOV. The simple moving average for the last 20 days is -6.35% for CLOV stock, with a simple moving average of -17.21% for the last 200 days.
Is It Worth Investing in Clover Health Investments Corp (NASDAQ: CLOV) Right Now?
The 36-month beta value for CLOV is at 1.93. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for CLOV is 382.10M, and currently, shorts hold a 5.35% of that float. The average trading volume for CLOV on June 16, 2025 was 5.69M shares.
CLOV) stock’s latest price update
Clover Health Investments Corp (NASDAQ: CLOV)’s stock price has increased by 2.28 compared to its previous closing price of 2.88. However, the company has seen a -0.98% decrease in its stock price over the last five trading sessions. zacks.com reported 2025-05-12 that Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Analysts’ Opinion of CLOV
Many brokerage firms have already submitted their reports for CLOV stocks, with Craig Hallum repeating the rating for CLOV by listing it as a “Buy.” The predicted price for CLOV in the upcoming period, according to Craig Hallum is $6 based on the research report published on December 17, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see CLOV reach a price target of $4. The rating they have provided for CLOV stocks is “Neutral” according to the report published on October 07th, 2024.
Cowen gave a rating of “Market Perform” to CLOV, setting the target price at $3 in the report published on February 02nd of the previous year.
CLOV Trading at -11.96% from the 50-Day Moving Average
After a stumble in the market that brought CLOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -39.41% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLOV starting from Edwards Carladenise Armbrister, who sale 200,000 shares at the price of $3.61 back on Mar 07 ’25. After this action, Edwards Carladenise Armbrister now owns 273,227 shares of Clover Health Investments Corp, valued at $722,000 using the latest closing price.
Priest Brady Patrick, the CEO of Home Care of Clover Health Investments Corp, sale 75,000 shares at $3.68 during a trade that took place back on Mar 06 ’25, which means that Priest Brady Patrick is holding 2,418,151 shares at $276,000 based on the most recent closing price.
Stock Fundamentals for CLOV
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.26 for the gross margin
The net margin for Clover Health Investments Corp stands at -0.02. The total capital return value is set at -0.07. Equity return is now at value -7.75, with -3.88 for asset returns.
Currently, EBITDA for the company is -44.94 million with net debt to EBITDA at 6.79. When we switch over and look at the enterprise to sales, we see a ratio of 0.9. The receivables turnover for the company is 10.75for trailing twelve months and the total asset turnover is 2.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.54.
Conclusion
In conclusion, Clover Health Investments Corp (CLOV) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
